Home Health Agency Valuation & EBITDA Multiples

Medicare certification is the single highest-weighted variable in home health valuation. Per Breakwater M&A, certified agencies command a 1.5–2x higher multiple than non-certified peers — a non-medical agency at $4M revenue clearing $400K EBITDA might achieve $1.2M–$2M enterprise value (3–5x), while a Medicare-certified agency at the same scale commands $2M–$3.2M (5–8x) [8]. Certification creates regulatory barriers to entry: a buyer cannot simply replicate a Medicare provider number in a new market, making the certified footprint uniquely valuable to acquirers [1].

Payor mix is the #1 internal value driver an owner controls. A diversified book — for example, approximately 40% Medicare / 30% Medicaid / 30% private/Medicare Advantage — lifts the multiple +1–2 turns versus a concentrated mix [8]. Single managed-care contract dependency above 80% is a severe drag and can trigger earnout structures or kill deals. The sector-wide headwind of a ~1.3% CY2026 Medicare payment reduction compounds reimbursement risk for Medicaid-heavy agencies, further widening the spread between diversified and concentrated payors [8][9].

"Star rating is the new currency" in home health M&A, per Home Care Business Broker [9]. Agencies rated 4.5–5 stars earn approximately a +1.5x multiple premium because high ratings function as a fast-screen proxy for clinical compliance quality — they signal to PE and strategic underwriters that post-close regulatory exposure is low. Conversely, open ADRs, RAC audit findings, or recent CMS survey deficiencies push an agency to the lower end of its applicable band regardless of EBITDA quality, creating an earnout or escrow obligation at close [8][9].

Crossing the multi-state platform threshold shifts the applicable multiple band from the 6–9x regional range to the 9–12x+ tier [1][2]. The defining 2026 anchor: Kinderhook Industries' all-cash agreement to acquire Enhabit Inc. (NYSE: EHAB) at ~$1.1B TEV, implying ~10.7x on $103.1M TTM Adjusted EBITDA, across 249 home-health and 117 hospice locations in 34 states, announced Feb 22, 2026 [2][3]. At this scale, PE platforms require mandatory seller rollover equity of 10–20%, with earnouts tied to maintaining CMS star rating and passing a post-close audit [9].

Industry caregiver turnover averages 60–80%; agencies holding sub-50% turnover significantly de-risk post-close operations and command a premium [8]. Clean compliance posture — no open ADRs, no active RAC audit findings, unblemished CMS survey history — works alongside the star-rating driver to eliminate the escrow / reserve set-asides that otherwise reduce net proceeds. A tenured Director of Nursing and Administrator staying through close adds a demonstrable transition premium, typically modeled as +$25K–$150K to enterprise value [9].